Breaking News

Lubrizol Acquires Bavaria Medizin Technologie GmbH

Expands Lubrizol’s medical device design, development and manufacturing capabilities

The Lubrizol Corp. has acquired Bavaria Medizin Technologie GmbH (BMT). This acquisition expands Lubrizol’s expertise in precision thermoplastic extrusion and product development, for the global medical device and pharmaceutical industries.  BMT developed the first commercial drug-coated balloon, the Paccocath catheter. Today, BMT holds over 50 patents and continues to innovate through self-funded R&D projects, as well as contract R&D services. BMT’s experience in the drug-coated balloo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters